A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus
Clinical trial NCT00541749 · COMPLETED
Trial details
- NCT number
- NCT00541749
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2007-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.